Sophie Raynaud

Sophie Raynaud

UNVERIFIED PROFILE

Are you Sophie Raynaud?   Register this Author

Register author
Sophie Raynaud

Sophie Raynaud

Publications by authors named "Sophie Raynaud"

Are you Sophie Raynaud?   Register this Author

34Publications

906Reads

33Profile Views

L-leucine increases translation of and in erythroblasts from del(5q) myelodysplastic syndrome patients.

Haematologica 2018 11 14;103(11):e496-e500. Epub 2018 Jun 14.

Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, and Oxford BRC Haematology Theme, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.190447DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278984PMC
November 2018

Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia.

J Mol Diagn 2017 01 14;19(1):92-98. Epub 2016 Nov 14.

Laboratory of Biochemistry and Molecular Biology, Hôpital Nord, Centre Hospitalo-Universitaire de Marseille, Marseille, France; INSERM, UMR_S 1072, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2016.08.006DOI Listing
January 2017

Cytogenetic place in managing myelodysplastic syndromes: an update by the Groupe francophone de cytogénétique hématologique (GFCH).

Ann Biol Clin (Paris) 2016 Oct;74(5):525-534

Laboratoire de cytogénétique et de biologie moléculaire, Service d'hématologie biologique, CBPAS, GHS, Hospices civils de Lyon, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/abc.2016.1154DOI Listing
October 2016

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).

Br J Haematol 2015 Oct 18;171(2):210-214. Epub 2015 Jun 18.

LLR Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744770PMC
October 2015

Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines.

Oncotarget 2014 Jun;5(12):4384-91

INSERM U1065, Mediterranean Center for Molecular Medicine (C3M), Nice, France; University of Nice, Nice, France; Department of Clinical hematology and Transplantation, CHU of Nice, Nice, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147331PMC
http://dx.doi.org/10.18632/oncotarget.2024DOI Listing
June 2014

Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine.

Am J Hematol 2013 Sep 23;88(9):780-3. Epub 2013 Jul 23.

Centre Méditerranéen de médecine moléculaire, INSERM U1065, CHU Nice, Hôpital Archet 1, Service Hématologie Clinique, 151 Route Saint Antoine de Ginestière, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23509DOI Listing
September 2013

Mechanism of action of the multikinase inhibitor Foretinib.

Cell Cycle 2011 Dec 1;10(23):4138-48. Epub 2011 Dec 1.

INSERM U895, Centre Meditérranéen de Médecine Moléculaire, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.10.23.18323DOI Listing
December 2011

Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells.

Oncotarget 2011 Nov;2(11):874-85

INSERM U895, Centre Méditerranéen de Médecine Moléculaire, Team Cell Death, Differentiation, Inflammation and Cancer, Nice, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259992PMC
http://dx.doi.org/10.18632/oncotarget.360DOI Listing
November 2011

Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagy.

Cell Cycle 2011 Jul 15;10(14):2339-43. Epub 2011 Jul 15.

Cell Death, Differentiation, Inflammation and Cancer Team, Inserm U895, Nice, France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/cc.10.14.16308
Publisher Site
http://dx.doi.org/10.4161/cc.10.14.16308DOI Listing
July 2011

Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays.

Clin Chem Lab Med 2011 May 9;49(5):873-5. Epub 2011 Feb 9.

Department of Nuclear Medicine, University Hospital and University Bordeaux, Pessac, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2011.144DOI Listing
May 2011

[Assessment of an immature platelet fraction (IFP%) in the diagnosis of thrombocytopenia].

Ann Biol Clin (Paris) 2010 Jul-Aug;68(4):415-20

Laboratoire d'hématologie, Hôpital de Cimiez, Nice.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/abc.2010.0449DOI Listing
September 2010

Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.

Cancer Res 2010 Feb 26;70(3):1042-52. Epub 2010 Jan 26.

INSERM 895, Team 2: Cell Death Differentiation and Cancer, Laboratoire d'Oncohématologie, Centre Hospitalier Universitaire de Nice, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-3537DOI Listing
February 2010

Cytogenetic analysis of 298 newly diagnosed cases of acute lymphoblastic leukaemia in Tunisia.

Hematol Oncol 2008 Jun;26(2):91-7

Laboratoire de Cytogénétique et de Biologie de la Reproduction, CHU Farhat Hached, Sousse, Tunisia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.840DOI Listing
June 2008

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.

Cancer 2008 Mar;112(6):1296-305

Department of Hematology/Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, Los Angeles, California 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23270DOI Listing
March 2008

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends.

Gene 2005 Aug;356:160-8

KIMCL, Abteilung fuer Humangenetik, Medizinische Universitaet Wien, Waehringerstr. 10, A-1090 Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gene.2005.04.032DOI Listing
August 2005